| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |